A brief summary of the key anti-CK antibodies used in the experimental environment is offered in Table ​Table11. among the important constraints of our analyze was only two immuno-markers have been carried out, therefore we recommend a far more as a result of IHC and genomic profiling of TNBC inside our population for superior knowledge of this